READ HERE: #Obesity #WeightManagement #GLP1 #Semaglutide #Wegovy #NovoNordisk #Endocrinology #MetabolicHealth #CardiometabolicHealth #HealthcareInnovation #LifestyleMedicine #PrecisionMedicine #PublicHealth #ClinicalResearch To view or add a comment, sign in The question I hear the most from patients starting GLP-1 therapy: "Do I have to be on this injection forever?" The ATTAIN-MAINTAIN trial, published in Nature Medicine on May 12, 2026, gives me the most useful data-driven answer I have had to that question
This includes: 1:1 access to dietitians and health coaches through the Oviva app , so youre never on your own
First, patients getting higher-than-intended doses often due to mislabeling or misunderstanding can experience severe nausea, vomiting, dehydration, and require urgent care
GLP-1 receptor agonists mimic natural gut hormones to reduce appetite, slow gastric emptying, and promote gradual weight reduction over 612 months
Clean the stopper again, draw the additional water, and inject it the same way, slowly along the vial wall
y l s la chn hon ho cho nhng ai mun c mt vng nch sch s, trng sng v thm tho